Mobile device-collected actigraphy as a tool for early detection and symptom monitoring in patients with pancreatic cancer
Pancreatic Ductal Adenocarcinoma is a difficult disease to detect early. The main purpose of this study is to determine if there is a association between physical activity and PDAC recurrence diagnosis. The secondary purpose to is examine the associations between activity and treatment toxicities.
Pancreatic Ductal Adenocarcinoma
- Diagnosis of pancreatic ductal adenocarcinoma within the a 12 month time period prior to enrollment OR Family member or friend with no current diagnosis of malignancy.
- Patients have undergone definitive therapy (surgery and/or radiotherapy.
- No physical or medical limitations that effect mobility.
- No medical conditions that limit physical performance or mobility like heart failure, pulmonary disease, or Parkinson's disease.
- Accelerometer-equipped smartphone (Apple iPhone 5S or newer or Android phones running Google Fit application).
- Not currently pregnant or breastfeeding
18 - 99
Healthy Volunteers Needed
Duration of Participation
This study will last up to 2 years and can require up to 24 visits to OHSU or up to 24 questionnaires given over the phone.
Niko Millington, Study Coordinator, 971-413-9244 or firstname.lastname@example.org
Knight Cancer Institute